Manhard Kimberly (CIK 0001202094)

Latest company ownership

Shares held
10,000
Last filed at
Aug 30, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4
HRTX - HERON THERAPEUTICS, INC. /DE/
Role: EVP, Drug Development
Shares held
4,564
Last filed at
Apr 17, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 28, 2024 Aug 30, 2024 Inhibrx Biosciences, Inc. Director Buy 95.0 +10,000 100.00% ✗ $139.8K
Apr 13, 2023 Apr 17, 2023 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 47.5 -1,417 -4.76% ✗ $4.1K
Oct 31, 2022 Jan 17, 2023 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 50.0 -357 -0.80% ✗ $962.1
Oct 13, 2022 Oct 17, 2022 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 47.5 -2,012 -9.82% ✗ $7.6K
Jul 13, 2022 Jul 15, 2022 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 47.5 -2,012 -12.06% ✗ $6.1K
Apr 29, 2022 May 4, 2022 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 58.8 - 0.00% ✓ $1.4K
Apr 13, 2022 Apr 15, 2022 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 46.3 -2,012 -15.62% ✗ $12.2K
Jan 13, 2022 Jan 14, 2022 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 46.3 -2,012 -22.15% ✗ $16.7K
Oct 13, 2021 Oct 15, 2021 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 47.5 -433 -11.70% ✗ $4.6K
Jul 13, 2021 Jul 15, 2021 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 47.5 -433 -15.01% ✗ $5.8K
Apr 30, 2021 May 4, 2021 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 58.8 - 0.00% ✓ $5.8K
Apr 13, 2021 Apr 15, 2021 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 47.5 -433 -20.95% ✗ $7.2K
Jan 13, 2021 Jan 15, 2021 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 47.5 -433 -34.64% ✗ $7.9K
Dec 22, 2020 Dec 23, 2020 HERON THERAPEUTICS, INC. /DE/ EVP, Drug Development Sell 10.0 -10,000 -100.00% ✓ $200K
Apr 30, 2020 May 1, 2020 HERON THERAPEUTICS, INC. /DE/ Executive VP, Drug Development Sell 58.8 - 0.00% ✓ $2.1K
Nov 29, 2019 Dec 3, 2019 HERON THERAPEUTICS, INC. /DE/ Executive VP, Drug Development Sell 7.5 -24,000 -100.00% ✓ $624K
Apr 30, 2019 May 2, 2019 HERON THERAPEUTICS, INC. /DE/ Executive VP, Drug Development Sell 58.8 - 0.00% ✓ $481.4
Oct 31, 2018 Nov 2, 2018 HERON THERAPEUTICS, INC. /DE/ Executive VP, Drug Development Sell 58.8 - 0.00% ✓ $3.5K
Oct 1, 2018 Oct 2, 2018 HERON THERAPEUTICS, INC. /DE/ Executive VP, Drug Development Sell 10.0 -6,000 -100.00% ✓ $192.4K
Jul 2, 2018 Jul 3, 2018 HERON THERAPEUTICS, INC. /DE/ Executive VP, Drug Development Sell 10.0 -6,000 -100.00% ✓ $225.2K
Mar 19, 2018 Mar 19, 2018 HERON THERAPEUTICS, INC. /DE/ Executive VP, Drug Development Sell 7.5 -18,000 -100.00% ✓ $540K
Jan 10, 2018 Jan 12, 2018 HERON THERAPEUTICS, INC. /DE/ Executive VP, Drug Development Sell 10.0 -7,584 -100.00% ✓ $151.7K
Apr 24, 2017 Apr 24, 2017 HERON THERAPEUTICS, INC. /DE/ Executive VP, Drug Development Sell 7.5 -21,542 -100.00% ✓ $330.3K
Jun 1, 2015 Jun 3, 2015 HERON THERAPEUTICS, INC. /DE/ Director Sell 20.0 -13,208 -100.00% ✗ $304.9K